FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase. III. Structure determination

Journal of Antibiotics

Volumn 56, Issue 2, 2003, Pages 181-185

  Mori, Hiroaki ^a   Urano, Yasuharu ^a   Kinoshita, Takayoshi ^a   Yoshimura, Seiji ^a   Takase, Shigehiro ^a   Hino, Motohiro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; DRUG METABOLITE; FR 235222; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; FUNGAL METABOLISM; GRAFT REJECTION; HUMAN; NUCLEAR MAGNETIC RESONANCE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION;

EID: 0037300543     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.181     Document Type: Article

References (17)

1. MOHAMÇVED, M. A.; H. ROBERTSON, T. A. BOOTH, S. BALUPURI, J. A. KIRBY & N. E. TOLKOFF-RUBIN: TGF-expression in renal transplant biopsies. Transplantation 69 (5): 1002-1005, 2000
2. MORI, H.: FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC). I. Taxonomy, fermentation, isolation and biological activities. J. Antibiotics 56: 72-79, 2003
3. MORi, H.: FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC). II. Biological activities in animal models. J. Antibiotics 56: 80-86, 2003
4. SHIONO, M. & M. M. WOOLFSON: Direct-space methods in phase extension and phase determination. I. Low-density elimination. Acta Cryst. A48: 451-456, 1992
5. FUJII, K.; Y. IKAI, H. OKA, M. SUZUKI & K-I. HARADA: A non-empirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: Combination of Marfey's method with mass spectrometry and its practical application. Anal. Chem. 69: 5146-5151, 1997
6. OHTANI, I.; T. KUSUMI, Y. KASHMAN & H. KAKISAWA: High-field FT NMR application of Mosher's method. The absolute configurations of marine terpenoids. J. Am. Chem. Soc. 113: 4092-4096, 1991
7. Hydrogenation of Trapoxin A yielded an α-hydroxyketone derivative and the configuration of the alcohol was established to be S by this method as expected.
8. ITAZAKI, H.; K. NAGASHIMA, K. SUGITA, H. YOSHIDA, Y. KAWAMURA, Y. YASUDA, K. MATSUMOTO, K. ISHII, N. UOTANI, H. NAKAI, A. TERUI, S. YOSHIMATSU, Y. IKENISHI & Y. NAKAGAWA: Isolation and structural elucidation of new cyclotetrapeptides, trapoxin A and B, having detranformation activities as antitumor agents. J. Antibiotics 43: 1524-1532, 1990
9. KAWAI, M.; D. H. RICH & J. D. WALTON: The structure and conformation of HC-Toxin. Biochem. Biophys. Res. Commun. 111(2): 398-403, 1983
10. HIROTA, A.; A. SUZUKI, K. AIZAWA & S. MURA: Mass spectrometric determination of amino acid sequence in Cy1-2, a novel cyclotetrapeptide from Cylindrocladium scoparium. Biomed. Mass Spectrom. 1 (1): 15-19, 1974
11. UMEHARA, K.; K. NAKAHARA, S. KIYOTO, M. IWAMI, M. OKAMOTO, H. TANAKA, M. KOHSAKA, H. AOKI & H. IMANAKA: Studies on WF-3161, a new antitumor antibiotic. J. Antibiotics 36: 478-483, 1983
12. CLOSSE, A. & R. HUGUENIN: Isolierung und strukturäufklarung von chlamydocin. Helv. Chim. Acta. 57: 533, 1974
13. DARKIN-RATTRAY, S. J.; A. M. GURNETT, R. W. MYERS, P. M. DULSKI, T. M. CRUMLEY, J. J. ALLOCCO, C. CANNOVA, P. T. MEINKE, S. L. COLLETTI, M. A. BEDNAREK, S. B. SINGH, M. A. GOETZ, A. W. DOMBROWSKI, J. D. POLISHOOK & D. M. SCHMATZ: Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylse. Proc. Natl. Acad. Sci. USA 93 (23): 13143-13147, 1996
14. MASUOKA, Y.; K. SHIN-YA, K. FURIHATA, K. NAGAI, K. SUZUKI, Y. HAYAKAWA & H. SETO: Phoenistatin, a new gene expression-enhancing substance produced by Acremonium fusigerum. J. Antibiotics 54: 187-190, 2001
15. This residue has been seen in TAN-1746 in a patent where it was described as an anti-cancer agent. See, YOSHIMURA, K.; S. TSUBOTANI & K. OKAZAKI: Japan Pat. 07-196686, 1995
16. The amino acid residue was also observed in a chlamydocin analogue with phytotoxic activities. We believe that this product is identical with TAN-1746. See, Gupta, S.; G. Peiser, T. Nakajima & Y-S. Hwang: Characterization of a phytotoxic cyclotetrapeptide, a novel chlamydocin analogue, from Verticillium coccosporum. Tetrahedron Letters 35 (33): 6009-6012, 1994
17. KIJIMA, M.; M. YOSHIDA, K. SUGITA, S. HORINOUCHI & T. BEPPU: Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268 (30): 22429-22435, 1993